Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease

被引：29

作者：

Bjorkqvist, M.

Petersen, A.

Carroll, J.

Nielsen, J.

Ecker, D.

Mulder, H.

Hayden, M. R.

Landwehrmeyer, B.

Brundin, P.

Leavitt, B. R.

机构：

[1] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada

[2] Univ British Columbia, Brian Res Ctr, Vancouver, BC V5Z 4H4, Canada

[3] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22100 Lund, Sweden

[4] Lund Univ, Dept Expt Med Sci, Unit Mol Metab, S-22100 Lund, Sweden

[5] Univ Copenhagen, Dept Med Genet, DK-1168 Copenhagen, Denmark

[6] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany

来源：

CLINICAL GENETICS | 2006年 / 70卷 / 01期

关键词：

D O I：

10.1111/j.1399-0004.2006.00636.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：78 / 79

页数：2

共 5 条

[1] CSF hypocretin levels are normal in Huntington's disease patients [J].

Gaus, SE ;

Lin, L ;

Mignot, E .

SLEEP, 2005, 28 (12) :1607-1608

[2] Relationship between CSF hypocretin levels and hypocretin neuronal loss [J].

Gerashchenko, D ;

Munillo-Rodriguez, E ;

Lin, L ;

Xu, M ;

Hallett, L ;

Nishino, S ;

Mignot, E ;

Shiromani, PJ .

EXPERIMENTAL NEUROLOGY, 2003, 184 (02) :1010-1016

[3] Biomarkers for neurodegenerative diseases [J].

Henley, SMD ;

Bates, GP ;

Tabrizi, SJ .

CURRENT OPINION IN NEUROLOGY, 2005, 18 (06) :698-705

[4] Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease [J].

Meier, A ;

Mollenhauer, B ;

Cohrs, S ;

Rodenbeck, A ;

Jordan, W ;

Meller, J ;

Otto, M .

BRAIN RESEARCH, 2005, 1063 (02) :201-203

[5] Orexin loss in Huntington's disease [J].

Petersén, Å ;

Gil, J ;

Björkqvist, M ;

Tanila, H ;

Araújo, IM ;

Smith, R ;

Popovic, N ;

Wierup, N ;

Norlén, P ;

Li, JY ;

Roos, RAC ;

Sundler, F ;

Mulder, H ;

Brundin, P .

HUMAN MOLECULAR GENETICS, 2005, 14 (01) :39-47

← 1 →